MA47112A - Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide - Google Patents

Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide

Info

Publication number
MA47112A
MA47112A MA047112A MA47112A MA47112A MA 47112 A MA47112 A MA 47112A MA 047112 A MA047112 A MA 047112A MA 47112 A MA47112 A MA 47112A MA 47112 A MA47112 A MA 47112A
Authority
MA
Morocco
Prior art keywords
delayed
modified
methods
release formulations
treating irritable
Prior art date
Application number
MA047112A
Other languages
English (en)
French (fr)
Inventor
Ahmad Hashash
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of MA47112A publication Critical patent/MA47112A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA047112A 2016-12-21 2017-12-21 Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide MA47112A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662437566P 2016-12-21 2016-12-21

Publications (1)

Publication Number Publication Date
MA47112A true MA47112A (fr) 2019-10-30

Family

ID=61022424

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047112A MA47112A (fr) 2016-12-21 2017-12-21 Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide

Country Status (10)

Country Link
EP (1) EP3558337A1 (zh)
JP (2) JP2020512292A (zh)
CN (1) CN110475564A (zh)
AU (1) AU2017379082A1 (zh)
BR (1) BR112019012689A2 (zh)
CA (1) CA3048195A1 (zh)
EA (1) EA201991531A1 (zh)
MA (1) MA47112A (zh)
MX (2) MX2019007574A (zh)
WO (1) WO2018119191A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114206324A (zh) * 2019-06-10 2022-03-18 硬木药品公司 治疗与腹泻占主导的肠易激综合征相关的腹部疼痛
CA3238619A1 (en) * 2021-11-29 2023-06-01 Michael Gerber Pharmaceutical compositions for the treatment of visceral pain
WO2023196821A2 (en) * 2022-04-04 2023-10-12 Thomas Jefferson University Targeting neuropod cell gucy2c to control visceral pain and appetite

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371727B2 (en) 2003-01-28 2008-05-13 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7304036B2 (en) 2003-01-28 2007-12-04 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
PE20151205A1 (es) 2008-08-15 2015-08-31 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para administracion oral
EP2464373A1 (en) * 2009-08-13 2012-06-20 Ironwood Pharmaceuticals, Inc. Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
UA108636C2 (xx) 2010-02-17 2015-05-25 Пептид
EP3626253B8 (en) * 2010-08-11 2022-04-20 Ironwood Pharmaceuticals, Inc. Stable formulations of linaclotide
PL2776055T3 (pl) 2011-08-17 2017-06-30 Ironwood Pharmaceuticals, Inc. Sposoby leczenia zaburzeń żołądkowo-jelitowych
CN105338958A (zh) * 2013-01-15 2016-02-17 铁木医药有限公司 胆汁酸螯合剂的胃内滞留缓释口服剂型
UA119335C2 (uk) * 2013-12-11 2019-06-10 Айронвуд Фармасьютикалз, Інк. Композиції лінаклотиду з затриманим вивільненням
JP2018516937A (ja) * 2015-06-05 2018-06-28 アイアンウッド ファーマシューティカルズ インコーポレイテッド リナクロチドの改変または標的放出製剤

Also Published As

Publication number Publication date
CA3048195A1 (en) 2018-06-28
JP2020512292A (ja) 2020-04-23
CN110475564A (zh) 2019-11-19
AU2017379082A1 (en) 2019-07-04
WO2018119191A1 (en) 2018-06-28
MX2023008839A (es) 2023-08-14
BR112019012689A2 (pt) 2019-11-19
MX2019007574A (es) 2019-09-04
EA201991531A1 (ru) 2019-11-29
WO2018119191A9 (en) 2018-10-18
JP2022093472A (ja) 2022-06-23
EP3558337A1 (en) 2019-10-30

Similar Documents

Publication Publication Date Title
MA43380A (fr) Récepteurs chimériques modifiés et compositions et procédés associés
MA45779A (fr) Polypeptides immunomdulateurs et compositions et procédés associés
MA50569A (fr) Ensembles de remplissage-finition et procédés associés
MA43711A (fr) Procédés de production de l-glufosinate
LT3368688T (lt) Kompozicijos ir būdai, skirti modifikuotų citozinų nustatymui sekvenavimu
MA52506A (fr) Procédés de traitement d'infections par des virus nipah
DK3329002T3 (da) Transthyretin (ttr)-irna-sammensætninger og fremgangsmåder til anvendelse deraf til behandling eller forebyggelse af ttr-forbundne sygdomme
MA40824A (fr) Particules de cmv de type virus modifié
IL266162A (en) Adeno-associated virus purification methods
MA46865A (fr) Compositions de caryophyllène, appareils et procédés
MA46927A (fr) Procédés de détection du cancer
IL251606B (en) Methods and systems for diagnosing irritable bowel syndrome from inflammatory bowel disease and celiac disease
DK3662925T3 (da) Sammensætning, der omfatter fsh, til behandling af infertilitet
MA47112A (fr) Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide
MA45574A (fr) Procédés de traitement de lésions ou de pathologies liées à un dème du snc
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
BR112017021850A2 (pt) detecção de isoformas específicas de clusterina
BR112016024667A2 (pt) composições de revestimento melhorado e processos para fabricação das mesmas
MA41961A (fr) Procédés de régénération d'adsorbants solides
MA52920A (fr) Compositions et procédés se rapportant à des agonistes de pyridinoylpipéridine 5-ht1f
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme
MA46711A (fr) Polysaccharide et procédés
MA43682A (fr) Procédés de traitement de l'intolérance au lactose
MA49688A (fr) Procédés de traitement du syndrome myélodysplasique
MA41202A (fr) Copolymères polydiallymine réticulé pour le traitement du diabète de type 2